GC Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$65M

GC Therapeutics (GCTx) develops off-the-shelf iPSC-based cell therapy products for gastrointestinal, neurological, and immunological diseases using their innovative TFome platform.

Total Funding

$75M

Headquarters

N/A

Founded

N/A

Website

gc-tx.com

Focus Areas

Synthetic biology

gene editing

cell engineering

machine learning

iPSC-based cell therapies

off-the-shelf cell therapy

Investors